Evaluation of anti-diabetic potential of chromium(III) propionate complex in high-fat diet fed and STZ injected rats

Food and Chemical Toxicology

Volumn 49, Issue 12, 2011, Pages 3217-3223

  Król, Ewelina ^a   Krejpcio, Zbigniew ^a,b  

^a POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

^b Faculty of Cosmetology and Educational Sciences   (Poland)

Author keywords

Anti diabetic potential; Chromium(III) propionate complex; Diabetes; Rat

Indexed keywords

CHROMIUM; CHROMIUM DERIVATIVE; CHROMIUM PROPIONATE COMPLEX; COPPER; GLUCOSE; IRON; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BIOACCUMULATION; CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; GLUCOSE BLOOD LEVEL; HYPERLIPIDEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID ANALYSIS; MALE; NONHUMAN; RAT; STREPTOZOCIN DIABETES; TISSUE LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIET, HIGH-FAT; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; KIDNEY; LIVER; MALE; PROPIONIC ACIDS; RATS; RATS, WISTAR; STREPTOZOCIN; TRIGLYCERIDES;

RATTUS; RATTUS NORVEGICUS;

EID: 80054857846     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2011.09.006     Document Type: Article

References (58)

1. Albarracin C., Fuqua B., Evans J.L., Goldfine I.D. Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type 2 diabetes. Diabetes Metabolism Research and Reviews 2008, 24(1):41-51.
2. Aribal-Kocatürk P., Kavas G.O., Büyükkaĝnici D.I. Pretreatment effect of resveratrol on streptozotocin-induced diabetes in rats. Biological Trace Element Research 2007, 118(3):244-249.
3. Arrese M. Nonalcoholic fatty liver disease: liver disease: an overlooked complication of diabetes mellitus. Nature Reviews Endocrinology 2010, 6:660-661.
4. Cefalu W.T., Rood J., Pinsonat P., Qin J., Sereda O., Levitan L., Anderson R.A., Zhang X.H., Martin J.M., Martin C.K., Wang Z.Q., Newcomer B. Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus. Metabolism 2010, 59:755-762.
5. CELL-DYN 1700 System, 1995. Operations Manual. Abbott Laboratories, USA.
6. Chen W.Y., Chen C.J., Liu C.H., Mao F.C. Chromium supplementation enhances insulin signalling in skeletal muscle of obese KK/HlJ diabetic mice. Diabetes Obesity Metabolism 2009, 11:293-303.
7. Cerulli J., Grabe D.W., Gauthier I., Malone M., McGoldrick M.D. Chromium picolinate toxicity. Annals of Pharmacotherapy 1998, 32(4):428-431.
8. Cheung, N., Mitchell, P., Wong, T.Y. 2010. Diabetic retinopathy. Lancet 10, 376(9735), 124-136.
9. + increases insulin sensitivity and improves blood plasma variables in healthy and type 2 diabetic rats. Journal of Biological Inorganic Chemistry 2005, 10:119-130.
10. Clodfelder B.J., Upchurch R.G., Vincent J.B. A comparison of the insulin-sensitive transport of chromium in healthy and model diabetic rats. Journal of Inorganic Biochemistry 2004, 98:522-533.
11. Clodfelder B.J., Vincent J.B. The time-dependent transport of chromium in adult rats from the bloodstream to the urine. Journal of Biological Inorganic Chemistry 2005, 10:383-393.
12. Di Bona K.R., Love S., Rhodes N.R., McAdory D., Sinha S.H., Kern N., Kent J., Strickland J., Wilson A., Beaird J., Ramage J., Rasco J.F., Vincent J.B. Chromium is not an essential trace element for mammals: effects of a " low-chromium" diet. Journal of Biological Inorganic Chemistry 2011, 16:381-390.
13. Dogukan A., Sahin N., Tuzcu M., Juturu V., Orhan C., Onderci M., Komorowski J., Sahin K. The effects of chromium histidinate on mineral status of serum and tissue in fat-fed and streptozotocin-treated type II diabetic rats. Biological Trace Element Research 2009, 131:124-132.
14. Dogukan A., Tuzcu M., Juturu V., Cikim G., Ozercan I., Komorowski J., Sahin K. Effects of chromium histidinate on renal function, oxidative stress, and heat-shock proteins in fat-fed and streptozotocin-treated rats. Journal of Renal Nutrition 2010, 20:112-120.
15. Earnshaw, A., Figgis, B.N., Lewis, J., 1966. Chemistry of polynuclear compounds. Part VI. Magnetic properties of trimeric chromium and iron carboxylates. Journal of Chemical Society A. 1656-1663.
16. Eaton J.W., Qian M. Interactions of copper with glycated proteins: possible involvement in the etiology of diabetic neuropathy. Molecular and Cellular Biochemistry 2002, 234-235:135-142.
17. EFSA, opinion on the safety of CrPic. 2010. EFSA Journal 8(12), 1883.
18. Flaherty A.W., 1991. Laboratory methods in hematology. In: Beck, W.S. (Ed.), Hematology. The MIT Press, Massachusetts, p. 606.
19. Gambert S.R., Pinkstaff S. Emerging epidemic: diabetes in older adults: demography, economic impact and pathophysiology. Diabetes Spectrum 2006, 19:221-228.
20. Goldfine A.B., Fonseca V. Management of diabetes mellitus in patients with cardiovascular disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Circulation 2010, 8(121):2447-2449.
21. Harton A., Terrell K., Huffman J.C., MacDonald C., Beatty A., Li S., O'Connor C.J., Vincent J.B. Synthesis and characterization of novel oxo-bridged dinuclear and hydroxo-bridged trinuclear chromium(III) assemblies. Inorganic Chemistry 1997, 36:4875-4882.
22. Islam M.S., Choi H. Nongenetic model of type 2 diabetes: a comparative study. Pharmacology 2007, 79:243-249.
23. Jain S.K., Croad J.L., Velusamy T., Rains J.L., Bull R. Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP-1, ICAM-1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFkappaB, Akt, and Glut-2 in livers of zucker diabetic fatty rats. Molecular Nutrition and Food Research 2010, 54:1371-1380.
24. Kandadi M.R., Unnikrishnan M.K., Warrier A.K., Du M., Ren J., Sreejayan N. Chromium (d-Phenylalanine)(3) alleviates high fat-induced insulin resistance and lipid abnormalities. Journal of Biological Inorganic Chemistry 2011, 105:58-62.
25. Kotseva K., Wood D., De Backer G., De Bacquer D., Pyörälä K., Reiner Z., Keil U., EUROASPIRE Study Group EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice. Cross-sectional survey in 12 European countries. European Journal of Cardiovascular Prevention and Rehabilitation 2010, 17:530-540.
26. Król E., Krejpcio Z. Chromium(III) propionate complex supplementation improves carbohydrate metabolism in insulin-resistance rat model. Food and Chemical Toxicology 2010, 48:2791-2796.
27. Król, E., Krejpcio, Z, Byks, H, Bogdański, P, Pupek-Musialik, D. 2010. Effects of chromium Brewer's yeast supplementation on body mass, blood carbohydrates, and lipids and minerals in type 2 diabetic patients. Biological Trace Element Research, doi:. doi:10.1007/s12011-011-8959-3.
28. Lee S.M., Yang H., Tartar D.M., Gao B., Luo X., Ye S.Q., Zaghouani H., Fang D. Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes. Diabetologia 2011, 54(5):1136-1346.
29. Machaliński B., Walczak M., Syrenicz A., Michalińska A., Grymuła K., Stecewicz I., Wiszniewska B., Da{ogonek}bkowska E. Hypoglycemic potency of novel trivalent chromium in hyperglycemic insulin-deficient rats. Journal of Trace Elements in Medicine and Biology 2006, 20:33-39.
30. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
31. Miki Y. A homogenous assay for the selective measurement of LDL-cholesterol in serum. Enzymatic selective protection method. Clinical Laboratory 1999, 45:398-401.
32. Newmann, D.J., Price, C.P., 1999. Renal function and nitrogen metabolites. In: Burtis, C.A., Ashwood, E.R. (Eds.), Tietz book of clinical chemistry. WB Saunders Company, Philadelphia, 1999, pp. 1239-1242.
33. Pattar G.R., Tackett L., Liu P., Elmendorf J.S. Chromium picolinate positively influences the glucose transporter system via affecting cholesterol homeostasis in adipocytes cultured under hyperglycemic diabetic conditions. Mutation Research 2006, 610:93-100.
34. Pei D., Hsieh C.H., Hung Y.J., Li J.C., Lee C.H., Kuo S.W. The influence of chromium chloride-containing milk to glycemic control of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Metabolism 2006, 55:923-927.
35. Racek J., Trefil L., Rajdl D., Mudrova V., Hunter D., Senft V. Influence of chromium- enriched yeast on blood glucose and insulin variables, blood lipids, and markers of oxidative stress in subjects with type 2 diabetes mellitus. Biological Trace Element Research 2006, 109:215-230.
36. Reed M.J., Meszaros K., Entes L.J., Claypool M.D., Pinkett J.G., Gadbois T.M., Reaven G.M. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 2000, 49:1390-1394.
37. Reeves P.G., Nielsen F.H., Fahey G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. Journal of Nutrition 1993, 123:1939-1951.
38. Rhodes N.R., McAdory D., Love S., Di Bona K.R., Chen Y., Ansorge K., Hira J., Kern N., Kent J., Lara P., Rasco J.F., Vincent J.B. Urinary chromium loss associated with diabetes is offset by increases in absorption. Journal of Biological Inorganic Chemistry 2010, 104:790-797.
39. Riesen W.F. Lipid metabolism. Clinical Laboratory Diagnostics 1998, 167-169. Use and Assessment of Clinical Laboratory Results, TH-Books Verlagssesellschaft, Frankfurt Main. L. Thomas (Ed.).
40. Sacks D.B., Bruns D.E., Goldstein D.E., Maclaren N.K., McDonald J.M., Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clinical Chemistry 2002, 48:436-472.
41. Sahin K., Gülar T., Sahin N., Ertas O.N. The effect of chromium added into basal diet on serum total protein, urea, triglyceride, cholesterol and serum and tissue chromium, zinc, copper levels in rabbits. Turkish Journal of Veterinary and Animal Sciences 1999, 23:113-119.
42. Sahin K., Onderci M., Tuzcu M., Ustundag B., Cikim G., Ozercan I.H., Sriramoju V., Juturu V., Komorowski J.R. Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat. Metabolism Clinical and Experimental 2007, 56:1233-1240.
43. Schumann G., Klauke R. New IFCC reference procedures for the determination of catalytic activity concentrations of five enzymes in serum: preliminary upper reference limits obtained in hospitalized subjects. Clinica Chimica Acta 2003, 327:69-79.
44. Shephard M.D., Whiting M.J. Falsely low estimation of triglycerides in lipemic plasma by the enzymatic triglyceride method with modified Trinder's chromogen. Clinical Chemistry 1990, 36:325-329.
45. Shinde U.A., Goyal R.K. Effects of chromium picolinate on histopatological alternations in STZ and neonatal STZ diabetic rats. Journal of Cellular and Molecular Medicine 2003, 7:322-329.
46. Soinio M., Marniemi J., Laakso M., Pyörälä K., Lehto S., Rönnemaa T. Serum zinc level and coronary heart disease events in patients with type 2 diabetes. Diabetes Care 2007, 30:523-538.
47. Srinivasan K., Viswanad B., Asrat L., Kaul C.L., Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacological Research 2005, 52:313-320.
48. Staniek H., Kostrzewska-Poczekaj M., Arndt M., Szyfter K., Krejpcio Z. Genotoxicity assessment of chromium(III) propionate complex in the rat model using the comet assay. Food and Chemical Toxicology 2010, 48:89-92.
49. Staniek H., Krejpcio Z. The effects of tricentric chromium(III) propionate complex supplementation on pregnancy outcome and maternal and foetal mineral status in rat. Food and Chemical Toxicology 2009, 47:2673-2678.
50. Staniek H., Krejpcio Z., Iwanik K. Evaluation of the acute oral toxicity class of tricentric chromium(III) propionate complex in rat. Food and Chemical Toxicology 2010, 48:859-864.
51. + decreases plasma insulin, cholesterol, and triglicerides in healthy and type II diabetic rats but not type I diabetic rats. Journal of Biological Inorganic Chemistry 2002, 7:852-862.
52. 3]+ decreases plasma cholesterol and triglycerides in rats: towards chromium-containing therapeutics. Journal of Biological Inorganic Chemistry 1999, 4:838-845.
53. Ścibor A., Zaporowska H. Effects of vanadium(V) and/or chromium(III) on l-ascorbic acid and glutathione as well as iron, zinc, and copper levels in rat liver and kidney. Journal of Toxicology and Environmental Health Part A 2007, 70:696-704.
54. Thomas L. Total protein. Clinical Laboratory Diagnostics 1998, 644-647. Use and Assessment of Clinical Laboartory Results. TH-Books Verlagsgesellschaft, FrankfuntMain. L. Thomas (Ed.).
55. Wieloch A., Wieczorek D., Staniek H., Szymusiak H., Krejpcio Z., Zieliński R. Tricentric complexes of chromium(III) with glycine and serine ligands. Current Trends in Commodity Science II 2007, 1080:1086.
56. Wu Y.L., Huang J., Liu J., Jin M.F., Gu M., Hong Y., Wu Z.R., 2011. Protective effect of recombinant human glucagon-like peptide-1 (rhGLP-1) pretreatment in STZ-induced diabetic mice. Journal of Peptide Science, doi:. doi:10.1002/psc.1352.
57. Zargar A.H., Shah N.A., Massodi S.R. Copper, zinc and magnesium levels in non-insulin dependent diabetes mellitus. Postgraduate Medicine Journal 1998, 74:665-668.
58. Zhang F., Ye C., Li G., Ding W., Zhou W., Zhu H., Chen G., Luo T., Guang M., Liu Y., Zhang D., Zheng S., Yang J., Gu Y., Xie X., Luo M. The rat model of type 2 diabetic mellitus and its glycometabolism characters. Experimental Animals 2003, 52(5):401-407.